You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Targeted Protein Degradation Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Market Analysis and Insights: Global Targeted Protein Degradation Market
The global Targeted Protein Degradation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Targeted Protein Degradation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Targeted Protein Degradation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Targeted Protein Degradation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Targeted Protein Degradation market.
Targeted Protein Degradation Breakdown Data by Type
Oral
Intravenous
Others
Targeted Protein Degradation Breakdown Data by Application
Hospital
Research Institute
Based on regional and country-level analysis, the Targeted Protein Degradation market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Targeted Protein Degradation market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
5AM Venture Management LLC
AbbVie Inc
Almac Group
Amgen Inc.
Bayer AG
Biogen Inc.
C4 Therapeutics
Cosmo Bio USA
Covance Inc
Eli Lilly and Company
Gilead Sciences, Inc
GlaxoSmithKline plc
Merck KGaA
Mission Therapeutics
Novartis AG
Pfizer Inc
Promega
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Protein Degradation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Intravenous
1.2.4 Others
1.3 Market by Application
1.3.1 Global Targeted Protein Degradation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institute
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Targeted Protein Degradation Market Perspective (2016-2027)
2.2 Targeted Protein Degradation Growth Trends by Regions
2.2.1 Targeted Protein Degradation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Targeted Protein Degradation Historic Market Share by Regions (2016-2021)
2.2.3 Targeted Protein Degradation Forecasted Market Size by Regions (2022-2027)
2.3 Targeted Protein Degradation Industry Dynamic
2.3.1 Targeted Protein Degradation Market Trends
2.3.2 Targeted Protein Degradation Market Drivers
2.3.3 Targeted Protein Degradation Market Challenges
2.3.4 Targeted Protein Degradation Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Targeted Protein Degradation Players by Revenue
3.1.1 Global Top Targeted Protein Degradation Players by Revenue (2016-2021)
3.1.2 Global Targeted Protein Degradation Revenue Market Share by Players (2016-2021)
3.2 Global Targeted Protein Degradation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Targeted Protein Degradation Revenue
3.4 Global Targeted Protein Degradation Market Concentration Ratio
3.4.1 Global Targeted Protein Degradation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Revenue in 2020
3.5 Targeted Protein Degradation Key Players Head office and Area Served
3.6 Key Players Targeted Protein Degradation Product Solution and Service
3.7 Date of Enter into Targeted Protein Degradation Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Protein Degradation Breakdown Data by Type
4.1 Global Targeted Protein Degradation Historic Market Size by Type (2016-2021)
4.2 Global Targeted Protein Degradation Forecasted Market Size by Type (2022-2027)

5 Targeted Protein Degradation Breakdown Data by Application
5.1 Global Targeted Protein Degradation Historic Market Size by Application (2016-2021)
5.2 Global Targeted Protein Degradation Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Targeted Protein Degradation Market Size (2016-2027)
6.2 North America Targeted Protein Degradation Market Size by Type
6.2.1 North America Targeted Protein Degradation Market Size by Type (2016-2021)
6.2.2 North America Targeted Protein Degradation Market Size by Type (2022-2027)
6.2.3 North America Targeted Protein Degradation Market Size by Type (2016-2027)
6.3 North America Targeted Protein Degradation Market Size by Application
6.3.1 North America Targeted Protein Degradation Market Size by Application (2016-2021)
6.3.2 North America Targeted Protein Degradation Market Size by Application (2022-2027)
6.3.3 North America Targeted Protein Degradation Market Size by Application (2016-2027)
6.4 North America Targeted Protein Degradation Market Size by Country
6.4.1 North America Targeted Protein Degradation Market Size by Country (2016-2021)
6.4.2 North America Targeted Protein Degradation Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Targeted Protein Degradation Market Size (2016-2027)
7.2 Europe Targeted Protein Degradation Market Size by Type
7.2.1 Europe Targeted Protein Degradation Market Size by Type (2016-2021)
7.2.2 Europe Targeted Protein Degradation Market Size by Type (2022-2027)
7.2.3 Europe Targeted Protein Degradation Market Size by Type (2016-2027)
7.3 Europe Targeted Protein Degradation Market Size by Application
7.3.1 Europe Targeted Protein Degradation Market Size by Application (2016-2021)
7.3.2 Europe Targeted Protein Degradation Market Size by Application (2022-2027)
7.3.3 Europe Targeted Protein Degradation Market Size by Application (2016-2027)
7.4 Europe Targeted Protein Degradation Market Size by Country
7.4.1 Europe Targeted Protein Degradation Market Size by Country (2016-2021)
7.4.2 Europe Targeted Protein Degradation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Market Size (2016-2027)
8.2 Asia-Pacific Targeted Protein Degradation Market Size by Type
8.2.1 Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Targeted Protein Degradation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2027)
8.3 Asia-Pacific Targeted Protein Degradation Market Size by Application
8.3.1 Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Targeted Protein Degradation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2027)
8.4 Asia-Pacific Targeted Protein Degradation Market Size by Region
8.4.1 Asia-Pacific Targeted Protein Degradation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Targeted Protein Degradation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Targeted Protein Degradation Market Size (2016-2027)
9.2 Latin America Targeted Protein Degradation Market Size by Type
9.2.1 Latin America Targeted Protein Degradation Market Size by Type (2016-2021)
9.2.2 Latin America Targeted Protein Degradation Market Size by Type (2022-2027)
9.2.3 Latin America Targeted Protein Degradation Market Size by Type (2016-2027)
9.3 Latin America Targeted Protein Degradation Market Size by Application
9.3.1 Latin America Targeted Protein Degradation Market Size by Application (2016-2021)
9.3.2 Latin America Targeted Protein Degradation Market Size by Application (2022-2027)
9.3.3 Latin America Targeted Protein Degradation Market Size by Application (2016-2027)
9.4 Latin America Targeted Protein Degradation Market Size by Country
9.4.1 Latin America Targeted Protein Degradation Market Size by Country (2016-2021)
9.4.2 Latin America Targeted Protein Degradation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Market Size (2016-2027)
10.2 Middle East & Africa Targeted Protein Degradation Market Size by Type
10.2.1 Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Targeted Protein Degradation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2027)
10.3 Middle East & Africa Targeted Protein Degradation Market Size by Application
10.3.1 Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Targeted Protein Degradation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2027)
10.4 Middle East & Africa Targeted Protein Degradation Market Size by Country
10.4.1 Middle East & Africa Targeted Protein Degradation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Targeted Protein Degradation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 5AM Venture Management LLC
11.1.1 5AM Venture Management LLC Company Details
11.1.2 5AM Venture Management LLC Business Overview
11.1.3 5AM Venture Management LLC Targeted Protein Degradation Introduction
11.1.4 5AM Venture Management LLC Revenue in Targeted Protein Degradation Business (2016-2021)
11.1.5 5AM Venture Management LLC Recent Development
11.2 AbbVie Inc
11.2.1 AbbVie Inc Company Details
11.2.2 AbbVie Inc Business Overview
11.2.3 AbbVie Inc Targeted Protein Degradation Introduction
11.2.4 AbbVie Inc Revenue in Targeted Protein Degradation Business (2016-2021)
11.2.5 AbbVie Inc Recent Development
11.3 Almac Group
11.3.1 Almac Group Company Details
11.3.2 Almac Group Business Overview
11.3.3 Almac Group Targeted Protein Degradation Introduction
11.3.4 Almac Group Revenue in Targeted Protein Degradation Business (2016-2021)
11.3.5 Almac Group Recent Development
11.4 Amgen Inc.
11.4.1 Amgen Inc. Company Details
11.4.2 Amgen Inc. Business Overview
11.4.3 Amgen Inc. Targeted Protein Degradation Introduction
11.4.4 Amgen Inc. Revenue in Targeted Protein Degradation Business (2016-2021)
11.4.5 Amgen Inc. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Targeted Protein Degradation Introduction
11.5.4 Bayer AG Revenue in Targeted Protein Degradation Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Biogen Inc.
11.6.1 Biogen Inc. Company Details
11.6.2 Biogen Inc. Business Overview
11.6.3 Biogen Inc. Targeted Protein Degradation Introduction
11.6.4 Biogen Inc. Revenue in Targeted Protein Degradation Business (2016-2021)
11.6.5 Biogen Inc. Recent Development
11.7 C4 Therapeutics
11.7.1 C4 Therapeutics Company Details
11.7.2 C4 Therapeutics Business Overview
11.7.3 C4 Therapeutics Targeted Protein Degradation Introduction
11.7.4 C4 Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021)
11.7.5 C4 Therapeutics Recent Development
11.8 Cosmo Bio USA
11.8.1 Cosmo Bio USA Company Details
11.8.2 Cosmo Bio USA Business Overview
11.8.3 Cosmo Bio USA Targeted Protein Degradation Introduction
11.8.4 Cosmo Bio USA Revenue in Targeted Protein Degradation Business (2016-2021)
11.8.5 Cosmo Bio USA Recent Development
11.9 Covance Inc
11.9.1 Covance Inc Company Details
11.9.2 Covance Inc Business Overview
11.9.3 Covance Inc Targeted Protein Degradation Introduction
11.9.4 Covance Inc Revenue in Targeted Protein Degradation Business (2016-2021)
11.9.5 Covance Inc Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Details
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Targeted Protein Degradation Introduction
11.10.4 Eli Lilly and Company Revenue in Targeted Protein Degradation Business (2016-2021)
11.10.5 Eli Lilly and Company Recent Development
11.11 Gilead Sciences, Inc
11.11.1 Gilead Sciences, Inc Company Details
11.11.2 Gilead Sciences, Inc Business Overview
11.11.3 Gilead Sciences, Inc Targeted Protein Degradation Introduction
11.11.4 Gilead Sciences, Inc Revenue in Targeted Protein Degradation Business (2016-2021)
11.11.5 Gilead Sciences, Inc Recent Development
11.12 GlaxoSmithKline plc
11.12.1 GlaxoSmithKline plc Company Details
11.12.2 GlaxoSmithKline plc Business Overview
11.12.3 GlaxoSmithKline plc Targeted Protein Degradation Introduction
11.12.4 GlaxoSmithKline plc Revenue in Targeted Protein Degradation Business (2016-2021)
11.12.5 GlaxoSmithKline plc Recent Development
11.13 Merck KGaA
11.13.1 Merck KGaA Company Details
11.13.2 Merck KGaA Business Overview
11.13.3 Merck KGaA Targeted Protein Degradation Introduction
11.13.4 Merck KGaA Revenue in Targeted Protein Degradation Business (2016-2021)
11.13.5 Merck KGaA Recent Development
11.14 Mission Therapeutics
11.14.1 Mission Therapeutics Company Details
11.14.2 Mission Therapeutics Business Overview
11.14.3 Mission Therapeutics Targeted Protein Degradation Introduction
11.14.4 Mission Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021)
11.14.5 Mission Therapeutics Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Targeted Protein Degradation Introduction
11.15.4 Novartis AG Revenue in Targeted Protein Degradation Business (2016-2021)
11.15.5 Novartis AG Recent Development
11.16 Pfizer Inc
11.16.1 Pfizer Inc Company Details
11.16.2 Pfizer Inc Business Overview
11.16.3 Pfizer Inc Targeted Protein Degradation Introduction
11.16.4 Pfizer Inc Revenue in Targeted Protein Degradation Business (2016-2021)
11.16.5 Pfizer Inc Recent Development
11.17 Promega
11.17.1 Promega Company Details
11.17.2 Promega Business Overview
11.17.3 Promega Targeted Protein Degradation Introduction
11.17.4 Promega Revenue in Targeted Protein Degradation Business (2016-2021)
11.17.5 Promega Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 105